Table 1.
Sociodemographic and Clinical Characteristics of Men Who Participated in the Focus Groups and Survey
| Variables | Focus Group 1 (n=5) | Focus Group 2 (n=3) | Focus Group 3 (n=6) | Survey (n=100) |
|---|---|---|---|---|
| Age, years; median | 71 | 62 | 72 | 68 |
| Race/ethnicity; n (%) | ||||
| White | 5 (100) | 3 (100) | 5 (83) | 88 (88) |
| Black/African American | 0 | 0 | 0 | 10 (10) |
| Other | 0 | 0 | 1 (17) | 2 (2) |
| Marital status; n (%) | ||||
| Married or partnered | 5 (100) | 2 (67) | 4 (67) | 80 (80) |
| Not married or partnered | 0 | 1 (33) | 2 (33) | 19 (19) |
| Employment status; n (%) | ||||
| Working | 35 (35) | |||
| Retired | 63 (63) | |||
| Health insurance status; n (%) | ||||
| Insured | 99 (99) | |||
| Not insured | 1 (1) | |||
| Self-reported health; n (%) | ||||
| Excellent or good | 68 (68) | |||
| Fair or poor | 30 (30) | |||
| Disease status; n (%) | ||||
| Biomedical recurrence | 1 (20) | 1 (33) | 1 (17) | 0 |
| Metastatic | 4 (80) | 2 (67) | 5 (83) | 100 (100) |
| Most recent PSA, ng/mL; M (SD) | 12.33 (23.66) | |||
| Site of metastasis; n (%) | ||||
| Bone | 79 (79) | |||
| Lymph node | 27 (27) | |||
| Liver | 2 (2) | |||
| Lung | 3 (3) | |||
| Other | 3 (3) | |||
| Do not know | 7 (7) | |||
| Total number of metastases; n (%) | ||||
| 1 | 77 (77) | |||
| 2 | 11 (11) | |||
| 3 | 5 (5) | |||
| Do not know | 7 (7) |
Notes: Only brief sociodemographic information was collected from focus group participants. Among survey participants, variables with missing data are age (n=96), marital status (n=99), employment status (n=98), self-reported health (n=98), and most recent PSA (n=97).
Abbreviations: M, mean; PSA, prostate-specific antigen.